Last updated: 5 September 2024 at 5:03pm EST

James L. Cunniff Net Worth




The estimated Net Worth of James L. Cunniff is at least $176 Thousand dollars as of 1 March 2024. James Cunniff owns over 9,000 units of Electromed stock worth over $176,400 and over the last few years James sold ELMD stock worth over $0.

James Cunniff ELMD stock SEC Form 4 insiders trading

James has made over 2 trades of the Electromed stock since 2023, according to the Form 4 filled with the SEC. Most recently James bought 9,000 units of ELMD stock worth $137,250 on 1 March 2024.

The largest trade James's ever made was buying 9,000 units of Electromed stock on 1 March 2024 worth over $137,250. On average, James trades about 2,500 units every 25 days since 2023. As of 1 March 2024 James still owns at least 10,000 units of Electromed stock.

You can see the complete history of James Cunniff stock trades at the bottom of the page.



What's James Cunniff's mailing address?

James's mailing address filed with the SEC is 500 SIXTH AVENUE NW, , NEW PRAGUE, MN, 56071.

Insiders trading at Electromed

Over the last 14 years, insiders at Electromed have traded over $2,585,226 worth of Electromed stock and bought 684,801 units worth $2,582,707 . The most active insiders traders include Oak Partners, Llc Red, Stephen H. Craney, and Kathleen Skarvan. On average, Electromed executives and independent directors trade stock every 84 days with the average trade being worth of $358,798. The most recent stock trade was executed by James L. Cunniff on 1 March 2024, trading 9,000 units of ELMD stock currently worth $137,250.



What does Electromed do?

electromed, inc. is a minnesota-based company (nyse mkt: elmd) and the innovative leader in the development, manufacture, and worldwide sales of the smartvest® airway clearance system. the patented system uses high frequency chest wall oscillation (hfcwo), a better-tolerated alternative to chest physiotherapy (cpt), to deliver vigorous, yet comfortable airway clearance treatment for patients battling the consequences of retained secretions. hfcwo has been clinically proven to clear the lungs of excess mucus, improve and reduce lung infections for individuals suffering from various conditions including atelectasis, copd, bronchiectasis, neuromuscular diseases, and cystic fibrosis. electromed, inc. is accredited by the joint commission and is iso 13485:2003 and iso 9001:2008 certified.



What does Electromed's logo look like?

Electromed Inc. logo

Complete history of James Cunniff stock trades at Electromed

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
1 Mar 2024 James L. Cunniff
CEO and President
Buy 9,000 $15.25 $137,250
1 Mar 2024
10,000
21 Nov 2023 James L. Cunniff
CEO and President
Buy 1,000 $10.56 $10,560
21 Nov 2023
1,000


Electromed executives and stock owners

Electromed executives and other stock owners filed with the SEC include: